Discoidin Domain Receptors and Disease

Chapter
First Online:

Abstract

The discoidin domain receptors have been implicated as contributing to normal developmental and pathologic conditions in humans. Mutations in the DDR genes have been described in a number of human diseases. Some of these are now being modeled in mice, which have afforded a better understanding for the cellular basis for the action of DDRs in various pathologic states. Herein, we first discuss the role(s) that DDR1 and DDR2 play in mouse development. Then we discuss pathologic conditions in humans where the action of DDRs has been associated with or correlated with pathologic and genomic analyses. Accumulated data indicate that the action of DDRs in various cell types have both cell-intrinsic roles as well as affecting the nature of the extracellular matrix produced or present in pathologic conditions.

Keywords

Cancer Inflammation Cardiovascular disease Fibrosis 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Vogel WF, Aszodi A, Alves F, Pawson T (2001) Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 21:2906–2917CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Faraci-Orf E, McFadden C, Vogel WF (2006) DDR1 signaling is essential to sustain Stat5 function during lactogenesis. J Cell Biochem 97:109–121CrossRefPubMedGoogle Scholar
  3. 3.
    Gross O et al (2004) DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney Int 66:102–111CrossRefPubMedGoogle Scholar
  4. 4.
    Meyer zum Gottesberge AM, Gross O, Becker-Lendzian U, Massing T, Vogel WF (2008) Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Lab Invest 88:27–37CrossRefPubMedGoogle Scholar
  5. 5.
    Labrador JP et al (2001) The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2:446–452CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kano K et al (2008) A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol Endocrinol 22:1866–1880CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Bargal R et al (2009) Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications. Am J Hum Genet 84:80–84CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ali BR et al (2010) Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients. Hum Mol Genet 19:2239–2250CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Olaso E et al (2002) Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem 277:3606–3613CrossRefPubMedGoogle Scholar
  10. 10.
    Kano K, Kitamura A, Matsuwaki T, Morimatsu M, Naito K (2010) Discoidin domain receptor 2 (DDR2) is required for maintenance of spermatogenesis in male mice. Mol Reprod Dev 77:29–37CrossRefPubMedGoogle Scholar
  11. 11.
    Ferri N, Carragher NO, Raines EW (2004) Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. Am J Pathol 164:1575–1585CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Hou G, Vogel W, Bendeck MP (2001) The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J Clin Invest 107:727–735CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hou G, Vogel WF, Bendeck MP (2002) Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circ Res 90:1147–1149CrossRefPubMedGoogle Scholar
  14. 14.
    Ahmad PJ et al (2009) Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. Am J Pathol 175:2686–2696CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Franco C et al (2008) Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circ Res 102:1202–1211CrossRefPubMedGoogle Scholar
  16. 16.
    Franco C, Ahmad PJ, Hou G, Wong E, Bendeck MP (2010) Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ Res 106:1775–1783CrossRefPubMedGoogle Scholar
  17. 17.
    Shyu KG, Wang BW, Chang H (2009) Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-alpha and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2. Clin Sci 116:575–583CrossRefPubMedGoogle Scholar
  18. 18.
    Hou G, Wang D, Bendeck MP (2012) Deletion of discoidin domain receptor 2 does not affect smooth muscle cell adhesion, migration, or proliferation in response to type I collagen. Cardiovasc Pathol 21:214–218CrossRefPubMedGoogle Scholar
  19. 19.
    Xu L et al (2005) Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem 280:548–555CrossRefPubMedGoogle Scholar
  20. 20.
    Xu L et al (2007) Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum 56:2663–2673CrossRefPubMedGoogle Scholar
  21. 21.
    Xu L et al (2011) Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model. Am J Pathol 179:1338–1346CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Xu L et al (2010) Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum 62:2736–2744CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Salazar A, Polur I, Servais JM, Li Y, Xu L (2014) Delayed progression of condylar cartilage degeneration, by reduction of the discoidin domain receptor 2, in the temporomandibular joints of osteoarthritic mouse models. J Oral Pathol Med 43:317–321CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Schminke B et al (2014) A discoidin domain receptor 1 knock-out mouse as a novel model for osteoarthritis of the temporomandibular joint. Cell Mol Life Sci 71:1081–1096CrossRefPubMedGoogle Scholar
  25. 25.
    Su J et al (2009) Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis. Mol Cell Biochem 330:141–152CrossRefPubMedGoogle Scholar
  26. 26.
    Avivi-Green C, Singal M, Vogel WF (2006) Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 174:420–427CrossRefPubMedGoogle Scholar
  27. 27.
    Olaso E, Arteta B, Benedicto A, Crende O, Friedman SL (2011) Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. Am J Pathol 179:2894–2904CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Olaso E et al (2001) DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest 108:1369–1378CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Luo Z et al (2013) RNA interference against discoidin domain receptor 2 ameliorates alcoholic liver disease in rats. PLoS One 8:e55860CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Rowe RG et al (2011) Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol 31:2392–2403CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Zhang K et al (2013) The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol 15:677–687CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R (2012) Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev 31:295–321CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ren T, Zhang J, Zhang J, Liu X, Yao L (2013) Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients. Med Oncol 30:397CrossRefPubMedGoogle Scholar
  34. 34.
    Toy KA et al (2015) Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res Treat 150:9–18CrossRefPubMedGoogle Scholar
  35. 35.
    Zhang S et al (2014) A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis. J Pathol 232:436–448CrossRefPubMedGoogle Scholar
  36. 36.
    Afonso PV, McCann CP, Kapnick SM, Parent CA (2013) Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices. Blood 121:1644–1650CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Hammerman PS et al (2011) Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov 1:78–89CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Tomasson MH et al (2008) Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood 111:4797–4808CrossRefPubMedGoogle Scholar
  39. 39.
    Ambrogio C et al (2016) Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma. Nat MedGoogle Scholar
  40. 40.
    Agarwal G, Kovac L, Radziejewski C, Samuelsson SJ (2002) Binding of discoidin domain receptor 2 to collagen I: an atomic force microscopy investigation. Biochemistry 41:11091–11098CrossRefPubMedGoogle Scholar
  41. 41.
    Xu H et al (2012) Discoidin domain receptors promote alpha1beta1- and alpha2beta1-integrin mediated cell adhesion to collagen by enhancing integrin activation. PLoS One 7:e52209CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Staudinger LA et al (2013) Interactions between the discoidin domain receptor 1 and beta1 integrin regulate attachment to collagen. Biol Open 2:1148–1159CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Hidalgo-Carcedo C et al (2011) Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol 13:49–58CrossRefPubMedGoogle Scholar
  44. 44.
    Eswaramoorthy R et al (2010) DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation. J Cell Physiol 224:387–397CrossRefPubMedGoogle Scholar
  45. 45.
    Rowe RG et al (2009) Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J Cell Biol 184:399–408CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Batlle R et al (2013) Snail1 controls TGF-beta responsiveness and differentiation of mesenchymal stem cells. Oncogene 32:3381–3389CrossRefGoogle Scholar
  47. 47.
    Shields MA et al (2013) Snail cooperates with KrasG12D to promote pancreatic fibrosis. Mol Cancer Res 11:1078–1087CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Shintani Y et al (2008) Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol 180:1277–1289CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Walsh LA, Nawshad A, Medici D (2011) Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. Matrix Biol 30:243–247CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Ren T et al (2014) Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia. J Pathol 234:526–537CrossRefPubMedGoogle Scholar
  51. 51.
    Kim HG, Hwang SY, Aaronson SA, Mandinova A, Lee SW (2011) DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J Biol Chem 286:17672–17681CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Valencia K et al (2012) Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Clin Cancer Res 18:969–980CrossRefPubMedGoogle Scholar
  53. 53.
    Badiola I, Villace P, Basaldua I, Olaso E (2011) Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncol Rep 26:971–978PubMedGoogle Scholar
  54. 54.
    Badiola I, Olaso E, Crende O, Friedman SL, Vidal-Vanaclocha F (2012) Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut 61:1465–1472CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Departments of Medicine (Oncology)The ICCE Institute, Washington UniversitySt. LouisUSA
  2. 2.Departments of Cell Biology and PhysiologyThe ICCE Institute, Washington UniversitySt. LouisUSA
  3. 3.Departments of BiochemistryThe ICCE Institute, Washington UniversitySt. LouisUSA

Personalised recommendations